ReviewMolecular neurobiology2021

Infliximab Can Improve Traumatic Brain Injury by Suppressing the Tumor Necrosis Factor Alpha Pathway.

Yiru Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.